Milne Ruairidh, Clegg Andrew, Stevens Andrew
Wessex Institute for Health Research and Development, University of Southampton, Southampton SO16 7PX.
J Public Health Med. 2003 Jun;25(2):102-6. doi: 10.1093/pubmed/fdg023.
Reports produced in response to the need for health technology assessment (HTA) vary greatly in the methods they use, depending on the decision-maker's needs, the technology's characteristics and the resources available. HTA reports vary from the brief, such as 'vignettes' produced when a new technology emerges, to the exhaustive, such as 'Cochrane reviews' synthesising a mature evidence base. They may address a wide range of different questions. 'Classic HTAs', typically those reports prepared to support NICE appraisal decisions, seek to use scientifically rigorous methods to address a focused policy question. These are based on systematic reviews of the effectiveness evidence but this is often fed into economic models, in order to generate estimates of cost-effectiveness. Future developments in HTA responses will reflect both the embedding of systematic methods and a growing responsiveness to customer needs.
为满足卫生技术评估(HTA)需求而编制的报告,其使用的方法差异很大,这取决于决策者的需求、技术的特点以及可用资源。HTA报告范围广泛,从新技术出现时产生的简短“案例”,到详尽的“Cochrane综述”(综合成熟的证据基础)。它们可能涉及各种各样不同的问题。“经典HTA”,通常是那些为支持英国国家卫生与临床优化研究所(NICE)评估决策而编写的报告,试图运用科学严谨的方法来解决一个重点突出的政策问题。这些报告基于对有效性证据的系统评价,但通常会纳入经济模型,以便得出成本效益估计值。HTA应对措施的未来发展将既反映系统方法的融入,也体现对客户需求日益增强的响应能力。